Track Chair:
Cindy Perettie, Kite Pharma

PMWC Award Ceremony
• Katy Rezvani, MD Anderson (Luminary)
• David Miklos, Stanford (Luminary)
• Frederick Locke, Moffitt Cancer Center (Luminary)

Featured Speakers
• Katy Rezvani, MD Anderson
• David Miklos, Stanford
• Frederick Locke, Moffitt Cancer Center
• Arie Belldegrun, Allogene Therapeutics
• Paul Hastings, Nkarta Therapeutics
• Priti Hegde, Kite Pharma
• Andrew Scharenberg, Umoja Biopharma
• Brett Staahl, Scribe Therapeutics
• Marcela Maus, Mass General Brigham / Harvard
• Antoni Ribas, UCLA
• Saul Priceman, USC
• Sabine Heitzeneder, Stanford

Off-the-Shelf Cell Therapies
NK, iPSC, and allogeneic T cells: what wins beyond autologous CAR-T.

AI in Cell Therapy: Research to Commercialization
How AI is reshaping discovery, product design, manufacturing, and clinical translation.

The Bottleneck: Manufacturing at Scale
Capacity, automation, cost of goods, and the realities of getting engineered cells to patients.

In Vivo Delivery: The Make-or-Break Layer
Targeting the right tissue safely enough to make in vivo engineering real.

Why Cell Therapies Fail in Solid Tumors and What Works
The microenvironment, antigen escape, and programs showing real responses.

Approved to Effective
Real-world outcomes, access, and what CAR-T still gets wrong after approval.